Menu Close

Trending

PARP rivals close in on AZ and Merck’s market leading Lynparza
Unlocking the potential of connected commercialisation solutions
Considerations for Mobile Health Technology Developers: Part 2
Novo Nordisk achieve headline results with icodec insulin
Roche gets FDA approval for HER2 breast cancer diagnostic

Nestlé Health Science

Bacteria

News/ News/ Sales and Marketing

Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug

, , , , , 0 Comment

Swiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million

X
Nestle gets closer to Seres, pledging $525m for microbiome C. diff drug
https://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/
Teamwork business concept

Debates/ Debates & Insight/ Insights/ Sales and Marketing/ Slider in whitepapers/ White Papers/ Whitepapers

Good data supports pharma sales reps to drive lead generation

, , 0 Comment

Allow pharma sales reps to focus on the job in hand by making sure they have access to

X
Good data supports pharma sales reps to drive lead generation
https://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/

Login

CONTINUE TO SITE >
X
Close in 10 seconds